These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 29035036)
1. Nanoprobe Synthesized by Magnetotactic Bacteria, Detecting Fluorescence Variations under Dissociation of Rhodamine B from Magnetosomes following Temperature, pH Changes, or the Application of Radiation. Alphandéry E; Abi Haidar D; Seksek O; Thoreau M; Trautmann A; Bercovici N; Gazeau F; Guyot F; Chebbi I ACS Appl Mater Interfaces; 2017 Oct; 9(42):36561-36572. PubMed ID: 29035036 [TBL] [Abstract][Full Text] [Related]
2. Correction to "Nanoprobe Synthesized by Magnetotactic Bacteria, Detecting Fluorescence Variations under Dissociation of Rhodamine B from Magnetosomes following Temperature, pH Changes, or the Application of Radiation". Alphandéry E; Abi Haidar D; Seksek O; Thoreau M; Trautmann A; Bercovici N; Gazeau F; Guyot F; Chebbi I ACS Appl Mater Interfaces; 2020 Nov; 12(47):53570. PubMed ID: 33180453 [No Abstract] [Full Text] [Related]
3. Chains of magnetosomes extracted from AMB-1 magnetotactic bacteria for application in alternative magnetic field cancer therapy. Alphandéry E; Faure S; Seksek O; Guyot F; Chebbi I ACS Nano; 2011 Aug; 5(8):6279-96. PubMed ID: 21732678 [TBL] [Abstract][Full Text] [Related]
4. Biocompatible coated magnetosome minerals with various organization and cellular interaction properties induce cytotoxicity towards RG-2 and GL-261 glioma cells in the presence of an alternating magnetic field. Hamdous Y; Chebbi I; Mandawala C; Le Fèvre R; Guyot F; Seksek O; Alphandéry E J Nanobiotechnology; 2017 Oct; 15(1):74. PubMed ID: 29041937 [TBL] [Abstract][Full Text] [Related]
5. Preparation of chains of magnetosomes, isolated from Magnetospirillum magneticum strain AMB-1 magnetotactic bacteria, yielding efficient treatment of tumors using magnetic hyperthermia. Alphandéry E; Guyot F; Chebbi I Int J Pharm; 2012 Sep; 434(1-2):444-52. PubMed ID: 22698862 [TBL] [Abstract][Full Text] [Related]
6. Smart Magnetotactic Bacteria Enable the Inhibition of Neuroblastoma under an Alternating Magnetic Field. Chen C; Wang P; Chen H; Wang X; Halgamuge MN; Chen C; Song T ACS Appl Mater Interfaces; 2022 Mar; 14(12):14049-14058. PubMed ID: 35311270 [TBL] [Abstract][Full Text] [Related]
7. Fluorescent magnetosomes for controlled and repetitive drug release under the application of an alternating magnetic field under conditions of limited temperature increase (<2.5 °C). Alphandéry E; Abi Haidar D; Seksek O; Guyot F; Chebbi I Nanoscale; 2018 Jun; 10(23):10918-10933. PubMed ID: 29850738 [TBL] [Abstract][Full Text] [Related]
8. Chains of magnetosomes with controlled endotoxin release and partial tumor occupation induce full destruction of intracranial U87-Luc glioma in mice under the application of an alternating magnetic field. Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Guyot F; Chebbi I J Control Release; 2017 Sep; 262():259-272. PubMed ID: 28713041 [TBL] [Abstract][Full Text] [Related]
9. Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma. Le Fèvre R; Durand-Dubief M; Chebbi I; Mandawala C; Lagroix F; Valet JP; Idbaih A; Adam C; Delattre JY; Schmitt C; Maake C; Guyot F; Alphandéry E Theranostics; 2017; 7(18):4618-4631. PubMed ID: 29158849 [TBL] [Abstract][Full Text] [Related]
10. Non-pyrogenic highly pure magnetosomes for efficient hyperthermia treatment of prostate cancer. Nguyen TN; Chebbi I; Le Fèvre R; Guyot F; Alphandéry E Appl Microbiol Biotechnol; 2023 Feb; 107(4):1159-1176. PubMed ID: 36633624 [TBL] [Abstract][Full Text] [Related]
11. Development of non-pyrogenic magnetosome minerals coated with poly-l-lysine leading to full disappearance of intracranial U87-Luc glioblastoma in 100% of treated mice using magnetic hyperthermia. Alphandéry E; Idbaih A; Adam C; Delattre JY; Schmitt C; Guyot F; Chebbi I Biomaterials; 2017 Oct; 141():210-222. PubMed ID: 28689117 [TBL] [Abstract][Full Text] [Related]
13. Unlocking the Potential of Magnetotactic Bacteria as Magnetic Hyperthermia Agents. Gandia D; Gandarias L; Rodrigo I; Robles-García J; Das R; Garaio E; García JÁ; Phan MH; Srikanth H; Orue I; Alonso J; Muela A; Fdez-Gubieda ML Small; 2019 Oct; 15(41):e1902626. PubMed ID: 31454160 [TBL] [Abstract][Full Text] [Related]
14. Applications of magnetosomes synthesized by magnetotactic bacteria in medicine. Alphandéry E Front Bioeng Biotechnol; 2014; 2():5. PubMed ID: 25152880 [TBL] [Abstract][Full Text] [Related]
15. Measuring magnetosomal pH of the magnetotactic bacterium Magnetospirillum magneticum AMB-1 using pH-sensitive fluorescent proteins. Eguchi Y; Fukumori Y; Taoka A Biosci Biotechnol Biochem; 2018 Jul; 82(7):1243-1251. PubMed ID: 29557302 [TBL] [Abstract][Full Text] [Related]
16. Bio-synthesized iron oxide nanoparticles for cancer treatment. Alphandéry E Int J Pharm; 2020 Aug; 586():119472. PubMed ID: 32590095 [TBL] [Abstract][Full Text] [Related]
17. Co-delivery of doxorubicin and recombinant plasmid pHSP70-Plk1-shRNA by bacterial magnetosomes for osteosarcoma therapy. Cheng L; Ke Y; Yu S; Jing J Int J Nanomedicine; 2016; 11():5277-5286. PubMed ID: 27822032 [TBL] [Abstract][Full Text] [Related]
18. Magnetotactic bacteria AMB-1 with active deep tumor penetrability for magnetic hyperthermia of hypoxic tumors. Chen X; Lai L; Li X; Cheng X; Shan X; Liu X; Chen L; Chen G; Huang G Biomater Sci; 2022 Nov; 10(22):6510-6516. PubMed ID: 36189964 [TBL] [Abstract][Full Text] [Related]
19. Stable pharmaceutical composition of cryo-protected non-pyrogenic isotonic chains of magnetosomes for efficient tumor cell destruction at 45 ± 1 °C under alternating magnetic field or ultrasound application. Nguyen TN; Chebbi I; Le Fèvre R; Guyot F; Alphandéry E Nanoscale; 2024 Oct; 16(40):18984-18997. PubMed ID: 39297787 [TBL] [Abstract][Full Text] [Related]
20. The effect of iron-chelating agents on Magnetospirillum magneticum strain AMB-1: stimulated growth and magnetosome production and improved magnetosome heating properties. Alphandéry E; Amor M; Guyot F; Chebbi I Appl Microbiol Biotechnol; 2012 Nov; 96(3):663-70. PubMed ID: 22707052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]